Newsletter registration

By using our website, you are agreeing to cookies being stored and Google Analytics being used on your device in order to offer the best possible service. You can find more information on thishere.
Austria.
Where Great Emphasis is Put on Research.

Adidas heirs invest in the Graz-based start-up Venuzle

Venuzle team © Venuzle

The Adidas heirs (IeAD) and Startup300 have now made fresh capital available to the company in Graz within the context of a new round of investment. IeAD Sports LTD now holds a 4.3 percent stake in the start-up, and the German IeAD accelerator owns an 8.7 percent shareholding. The founders continue to own more than 70 percent of the company. Venuzle aims to primarily invest the new inflow of capital in market development.

Eversports is another start-up in Austria dedicated to linking people to sports facilities. Eversports raised fresh capital in the spring and has also acquired other start-ups in Germany and Austria in order to expand. In Germany Eversports recently purchased Appointman, the largest competitor, which also processes about 150,000 bookings each month. Eversports focuses on private sports offerings, whereas Venuzle’s specialty is municipal offerings.

Share on Facebook Share on Facebook Share on Twitter Share on Twitter Share on Linkedin Share on Linkedin

Testimonials

Events

Meet us at events, seminars and trade shows - worldwide.

  • 17. Mittelstandstag FrankfurtRheinMain

    07.11.2019, Frankfurt on the Main, Germany

  • MEDICA 2019

    18.11.- 21.11. 2019, Dusseldorf, Germany, Germany

Austria Map

Find the perfect location for your company

The "mental closeness" of Austria to its neighbours is an important advantage for establishing new business contacts.

Ericsson Austria

Logo
More testimonials

news from the business location Austria

Siemens: New robot welding plant in Graz

Siemens Mobility has put a new robot-controlled frame welding facility into operation in Graz.

Coming back for seconds: Why big brands expand their (R&D) presence in Austria

The high-tech multinational Infineon is investing more than EUR 1.6 billion to expand its main facility in Austria. The pharmaceutical company Octapharma is massively expanding its Vienna-based operations at a cost of EUR 142 million. Headlines like these have recently caused people to sit up and take notice. But the question is: why is Austria as a research location so popular with international firms which are already established here?

More news All blog posts